Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Barrick Gold Corp (B) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
Barrick Gold CorpTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs Barrick Gold Corp — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $221.2 (market cap $29.03B), while Barrick Gold Corp trades at $40.8 (market cap $68.49B). The key difference: Barrick Gold Corp is far larger — about 2.4× Alnylam Pharmaceuticals, Inc.'s market cap, and Barrick Gold Corp pays a 1.71% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.

ALNYB
Market Cap
$29.03B$68.49B
Sector
HealthBasic Materials
52-Week High
$491.22$52.97
52-Week Low
$205.48$23.50
Enterprise Value
$26.99B$66.08B
Dividend Yield
1.71%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About Barrick Gold Corp

Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.

Read more on B